M31.19
BillableOther thrombotic microangiopathy
HCC Category Mapping
V28HCC 112 — Von Willebrand Disease and Other Coagulation Defects
0.247V24HCC 40 — Rheumatoid Arthritis and Inflammatory Connective Tissue Disease
0.307ESRDHCC 40 — Rheumatoid Arthritis and Inflammatory Connective Tissue Disease
0.000RxHCCHCC 84 — Vasculitis and Other Autoimmune Disorders
0.000What This Code Means
A condition where small blood vessels become blocked by clots due to causes other than stem cell transplantation, such as certain medications or infections.
Coding Tips
- •Document the underlying cause when identified (e.g., drug-induced, infection-related)
- •Use when the thrombotic microangiopathy is secondary to a known condition
Clinical Significance
Other thrombotic microangiopathy includes drug-induced, infection-associated, or other secondary forms of TMA not related to transplantation. These conditions still carry significant morbidity and mortality risk, requiring rapid identification of underlying causes and aggressive supportive care.
Documentation Requirements
- ✓Clinical evidence of thrombotic microangiopathy
- ✓Documentation of suspected underlying cause
- ✓Exclusion of transplant-associated TMA
- ✓Laboratory evidence of microangiopathic process
- ✓Assessment of organ involvement
- ✓Treatment response to cause-specific therapy
- ✓Monitoring for complications
- ✓Documentation of precipitating factors
Commonly Confused Codes
M31.11 — HSCT-associated TMA (when transplant-related)M31.10 — Thrombotic microangiopathy, unspecified (when cause is identified)D59.3 — Hemolytic-uremic syndrome (when HUS criteria are met)M31.1 — Thrombotic thrombocytopenic purpura (when TTP is diagnosed)T88.7 — Unspecified adverse effect of drug or medicament (when drug-induced)
Code Hierarchy
└M31Other necrotizing vasculopathies└M31.1Thrombotic microangiopathy└M31.19Other thrombotic microangiopathy
└M31.19Other thrombotic microangiopathy